The National Science Advisory Board for Biosecurity (NSABB) will convene virtually on Sept. 21, 2022, to discuss its progress in reviewing existing U.S. biosecurity oversight frameworks governing research with enhanced potential pandemic pathogens and dual-use research of concern. This meeting will be videocast and members of the public are encouraged to provide comments either orally or in writing.
The NSABB is a federal advisory committee chartered to provide, advice, guidance, and recommendations to the U.S. government regarding potential biosecurity implications of life sciences research, an issue of paramount importance to the Department of Health and Human Services, the National Institutes of Health, and the broader U.S. government.
Wednesday, Sept. 21, 2022, 1-5 p.m. EDT
Webcast Information: https://videocast.nih.gov
Information on how to participate.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®